MedPath

Intellipharmaceutics Corp

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

FDA:3
CANADA:2

Drug Approvals

Desvenlafaxine

Approval Date
Nov 6, 2018
FDA

Venlafaxine Hydrochloride

Approval Date
Oct 9, 2018
FDA

Levetiracetam

Approval Date
Dec 6, 2017
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.